Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS)

Published:2014-08 Issue:2 Volume:235 Page:463-469
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Zhao Shuiping,Wang Yongjun,Mu Yiming,Yu Bilian,Ye Ping,Yan Xiaowei,Li Zhanquan,Wei Yidong,Ambegaonakr Baishaili M.,Hu Dayi

Funder

Merck & Co., Ltd

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Major causes of death among men and women in China;He;N Engl J Med,2005

2. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study;Yusuf;Lancet,2004

3. Serum lipids and lipoproteins in Chinese men and women;Yang;Circulation,2012

4. Dyslipidemia management in adults with diabetes;American Diabetes Association (ADA);Diabetes Care,2004

5. Lipid control in the management of type 2 diabetes mellitus: a clinical practice guideline from the American college of physicians;Snow;Ann Intern Med,2004

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab;Pharmacological Research;2024-09

2. Efficacy and safety of ongericimab given by prefilled syringe or autoinjector in primary hypercholesterolemia and mixed hyperlipidemia;Nutrition, Metabolism and Cardiovascular Diseases;2024-09

3. Fasting hypertriglyceridemia in relation to mortality in an elderly male Chinese population;The Journal of Clinical Hypertension;2024-08-19

4. Ocular rosacea without facial erythema involvement manifesting as bilateral multiple recurrent chalazions: A case report;World Journal of Clinical Cases;2024-06-16

5. Medium-intensity statin with ezetimibe versus high-intensity statin in acute ischemic cerebrovascular disease (MESIA): A randomized clinical trial;Journal of Stroke and Cerebrovascular Diseases;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3